Three IHH Healthcare hospitals in Singapore installed QIAstat-Dx syndromic testing system, which is expected to enhance pathogen identification. Parkway Laboratories, in partnership with Netherlands-based biomedical solutions firm Qiagen, installed the system on IHH Healthcare’s Gleneagles, Mount Elizabeth, and Mount Elizabeth Novena hospitals. It is expected to enhance patient management by optimizing syndromic testing diagnosis and treatment with accurate pathogen identification.  QIAstat-Dx employs single-use cartridges with built-in sample processing and on-board reagents. It detects and differentiates between multiple pathogens, with results in about an hour, providing rapid answers for the detection of a wide range of infections.   https://sbr.com.sg/healthcare/news/ihh-hospitals-install-advanced-pathogen-identification-system (ICE SINGAPORE)

Fonte notizia: Singapore Business Review, 21 August 2024